TABLE 4.
Biochemical values before and after an AD and HD in hyperinsulinemic adults1
| AD | HD | Changes between groups | |||
|---|---|---|---|---|---|
| 0 wk | 6 wk | 0 wk | 6 wk | P value | |
| Serum fasting glucose, mmol/L | 5.3 ± 0.5 | 5.3 ± 0.6 | 5.3 ± 0.5 | 5.4 ± 0.5 | 0.89 |
| Serum fasting insulin, pmol/L | 121 ± 58 | 129 ± 77 | 111 ± 52 | 127 ± 68 | 0.73 |
| HOMA-IR | 4.8 ± 2.5 | 5.2 ± 3.8 | 4.4 ± 2.3 | 5.2 ± 3.4 | 0.77 |
| Serum glucose 2 h post-OGTT, mmol/L | 7.4 ± 2.9 | 7.1 ± 2.4 | 7 ± 2.3 | 7.3 ± 2.8 | 0.86 |
| Serum AUC glucose, mmol/L × h | 1.8 ± 0.3 | 1.8 ± 0.3 | 1.7 ± 0.3 | 1.8 ± 0.3 | 0.56 |
| Serum AUC insulin, pmol/L × h | 154 ± 81 | 160 ± 87 | 161 ± 76 | 158 ± 270 | 0.56 |
| Serum AUC C-peptide, pmol/L × h | 480 ± 103 | 487 ± 133 | 472 ± 125 | 474 ± 101 | 0.69 |
| Matsuda index | 6.6 ± 3.2 | 6.8 ± 4.4 | 7.2 ± 4.8 | 6.2 ± 3.1 | 0.96 |
| Insulinogenic index | 214 ± 108 | 209 ± 111 | 199 ± 82 | 240 ± 152 | 0.67 |
| Disposition index | 506 ± 259 | 511 ± 243 | 537 ± 270 | 493 ± 225 | 0.46 |
1
n = 27. Values are means ± SDs. Differences between groups after 6 wk were analyzed using a mixed model with treatment, visit, and treatment × visit as fixed attributes adjusted for age, sex, and BMI, with subjects as the random statement and visits as the repeated statement. AD, adequate dairy product intake; HD, high dairy product intake; OGTT, oral-glucose-tolerance test.